Co-op key to solve disease and bioterror – lack of co-op causes failure of aid and global disease pandemics – extinction
Bouey and Feng ‘17
Jennifer, behavioral epidemiologist @georgetown, and Cheng, dir. of global health program @ research center for public health, 05-08-17, "US-China Dialogue on Global Health Background Report," Georgetown Initiative for US-China Dialogue on Global Issues , https://fas.org/sgp/crs/row/IF10119.pdf
The health threat posed by migration has recently reared its head in China. An outbreak of yellow fever that began in Angola in December 2015 spread to China three months later, marking the first case of yellow fever ever reported in all of Asia, followed by 10 more Chinese cases imported from Angola by May. Yellow fever is a sometimes deadly disease caused by a mosquito-borne virus. While no cure exists, there is a vaccine, but it is generally administered only to those living in or traveling to areas where the disease is endemic. As such, China’s 1.4 billion citizens are almost universally unvaccinated. The Chinese cases came from Chinese workers returning home after having worked in Angola, where over 200,000 Chinese workers are employed on work visas for China’s aid and investment projects in the country.46 Chinese authorities do require travelers to Angola to be vaccinated for yellow fever, but there are fears that many of the Chinese workers there may not have abided by this rule. The spread of yellow fever to China is particularly worrisome given the region’s massive population and the fact that the primary vector of transmission— the Aedes aegypti mosquito—is common across much of China and nearby countries in South and Southeast Asia. Many epidemiologists have voiced concerns about how dangerous this confluence of factors could prove to be. So far, the United States and China have each responded to Angola’s yellow fever epidemic separately. In addition to increasing domestic mosquito monitoring and control activities to boost its own preparedness, the Chinese government provided Angola with half a million dollars in emergency assistance in February, before the outbreak had even spread to China.47 The CDC’s Mozambique Field Epidemiology Training Program graduates have collaborated with Angola’s Ministry of Health to track down suspected cases of yellow fever and intervene accordingly.48 With so much recent discussion between U.S. and Chinese health authorities regarding cooperative health security efforts in Africa, the tragic yellow fever outbreak offers the two countries an opportunity to achieve significant collaborative action on global health, if they choose to embrace it. The recent concerns of yellow fever epidemic also brought attention to China’s vaccine production. The global vaccine industry has long been dominated by a few multinational companies. In the past decade, vaccine manufacturers from China, India, and other emerging economies entered the international market and helped to drive down the vaccine price. For Jiankang Zhang, representative for PATH’s China Programs, the growth of China’s vaccine industry is “a very positive development for global health, as governments and international procurement agencies will be able to afford more life-saving vaccines and thus protect more lives.” A Chinese vaccine manufacturer obtained the first WHO prequalification vaccine (the Japanese encephalitis vaccine) in October 2013.49 Hope has been high that other vaccines manufactured from China will be qualified and enter the global market before the next pandemic. In the wake of the yellow fever epidemic in 2016, China’s Sinovac Biotech pledged to provide sufficient yellow fever vaccine supply for all Chinese expatriate workers.50 As the world is wondering what the next global pandemic will be, China’s vaccine manufacturing capacity may soon become one of the keys to stemming a potential global crisis. A final global health threat for the United States and China to consider as an area for greater cooperation is bioterrorism. Bilateral cooperation on counterterrorism is long established, but there is little evidence of collaboration in combating bioterrorism. Microsoft founder Bill Gates recently brought this issue into sharp relief at the Munich Security Conference that was attended by 450 senior decision makers from around the globe. Gates warned that “whether it occurs by a quirk of nature or at the hand of a terrorist, a fast-moving airborne pathogen could kill more than 30 million people in less than a year.”51 Among other recommendations, he advocated that countries need to prepare for pandemics in the same manner that the military prepares for war—with “germ games” and other pandemic exercises. He concluded that bioterrorism now ranks with nuclear war and climate